维普中文期刊产品整合服务
428篇 您的检索式:作者名="PIETERS R"
    题名 作者 年代 出处 被引量
1Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk显示文摘AIM: To investigate the role that single nucleotide polymorphisms (SNPs) in the promoter of the tumour necrosis factor-alpha (TNF-α) gene play in the risk of inflammatory bowel diseases (IBDs) in a New Zealand population, in the context of international studies. METHODS: DNA samples from 388 patients with Crohn's disease (CD), 405 ulcerative colitis (UC), 27 indeterminate colitis (IC) and 201 randomly selected controls, from Canterbury, New Zealand were screened for 3 common polymorphisms in the TNF-α receptor: -238 G→A, -308 G→A and -857C→T, using a TaqmanR assay. A meta-analysis was performed on the data obtained on these polymorphisms combined with that from other published studies. RESULTS: Individuals carrying the -308 G/A allele had a significantly (OR = 1.91, χ2 = 17.36, P < 0.0001) increased risk of pancolitis, and a 1.57-fold increased risk (OR = 1.57, χ2 = 4.34, P = 0.037) of requiring a bowel resection in UC. Carrying the -857 C/T variant decreased the risk of ileocolonic CD (OR = 0.56, χ2 =4.32, P = 0.037), and the need for a bowel resection (OR = 0.59, χ2 = 4.85, P = 0.028). The risk of UC was reduced in individuals who were smokers at diagnosis, (OR = 0.48, χ2 = 4.86, P = 0.028). CONCLUSION: TNF-α is a key cytokine known to play a role in inflammatory response, and the locus for the gene is found in the IBD3 region on chromosome 6p21, known to be associated with an increased risk for IBD. The -308 G/A SNP in the TNF-α promoter is functional, and may account in part for the increased UC risk associated with the IBD3 genomic region. The -857 C/T SNP may decrease IBD risk in certain groups. Pharmaco- or nutrigenomic approaches may be desir- able for individuals with such affected genotypes.Lynnette R Ferguson Claudia Huebner Ivonne Petermann Richard B Gearry Murray L Barclay Pieter Demmers Alan McCulloch Dug Yeo Han 2008World Journal of Gastroenterology2008,14,29:7
2Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial显示文摘Friedrich W Mohr Marie-Claude Morice A Pieter Kappetein Ted E Feldman Elisabeth St?hle Antonio Colombo Michael J Mack David R Holmes Marie-angèle Morel Nic Van Dyck Vicki M Houle Keith D Dawkins Patrick W Serruys 2013The Lancet . 2013 (9867)2013,,9867:2
3The p rog-nostic significance of membrane transport2associated multidrug resistance (MDR) proteins in leukenia 显示文摘Van der Heuvel-EibrinkM M Sonneveld P Pieters R 2000Int J Clin Pharmacol Ther2000,38,3:1
4Mutation of Tyrosine Residues Involved in the Alkylation Half Reaction of Epoxide Hydrolase from Agrobacterium radiobacter AD1 Results in Improved Enantioselectivity显示文摘 Spelberg J H K Pieters R J 1999J Am Chem Soc1999,12,17:1
5In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia 显示文摘Kaspers GJ Veerman A J Pieters R 1997Blood1997,90,7:1
6The N2myc paradox:N2myc overexpression in neurblastoma is associated wit h sensi2tivity as well as resistance to apoptosis显示文摘Nosel M M Pieters R Voute P A 2003Cancer Lett2003,197,12:1
7Biological and therapeutic aspects of infant leukemia 显示文摘Biondi A Cimino G Pieters R 2000Blood2000,96,:1
8Unrelated medi- cal costs in life-years gained 显示文摘DAVID R R PIETER H M B JOB A E 2008Pharmacoeconomics2008,26,10:1
9Identification of tumor - related proteins by preteomic analysis of cerebrospinal fluid from patients with primary brain tumors 显示文摘Zheng PP Luider TM Pieters R 2003Neurepathol Exp Neurol2003,62,8:1
10Eye fixations on advertisements and memory of brands:A model and findings显示文摘WedeI M Pieters R 0,,04:1
11Mutation of tyrosine residues involved in the alkylation half reaction of epoxide hydrolase from Agrobacterium radiobacter AD1 results in improved enantioselectivity显示文摘Rink R Spelberg J H L Pieters R J 0,,32:1
12Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention显示文摘Pascalle S Monraats Yue Fang Douwe Pons Nuno MM Pires Huibert AP Pols Aeilko H Zwinderman Moniek PM de Maat Pieter AF Doevendans Robbert J deWinter René A Tio Johannes Waltenberger Rune R Frants Paul HA Quax Arnoud van der Laarse Ernst E van der Wall Andr 2010Expert Opinion on Therapeutic Targets2010,,:1
13Dynamic monolayer behavior of a photo - responsive azobenzene surfactant 显示文摘INSUN K JOHN F R PIETER S 2000Colloids and Surfaces A: Physicochemical and Engineering Aspects2000,171,:1
14Modeling of equiaxed microstructure formation in casting显示文摘Pieters R 1987Phys Rev A1987,37,:1
15Sales Effects of Visual Attention tofeature ads: A Bayesian Mediation Analysis显示文摘Zhang J M Wedel R Pieters 2009Journal of Mar-keting Research2009,46,5:1
16Towards targeted therapy for infant acute lymphoblastic leukaemia显示文摘Stam RW den Boer ML Pieters R 2006Br J Haematol2006,132,5:1
17Murine models of drug hypersensitivity显示文摘Nierkens S Pieters R 2005Curr Opin Allergy Clin Immunol2005,5,4:1
18prospective proof of concept study of the efficacy of tacrolimus ointment onuraemicpruritus (UP) in patients on chronic dialysis therapy显示文摘Dirk R Kuypers Kathleen Claes Pieter Eveneplel 2004Nephrol Dial Transplant2004,19,:1
19In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia 显示文摘STYCZYNSKI J PIETERS R HUISMANS D R 2000Br J Haematol2000,110,:1
20Particle Erosion Resistance of Laser Nitrided Ti- 6A1 - 4V显示文摘Pieters R 2001Surface Engineering2001,17,2:1
返回顶部 每页显示:
共22页 首页 上一页 第1页 下一页 末页 /22 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费